| Anaemia | Blood and lymphatic system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0003 events3 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Atrioventricular block first degree | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Bradycardia | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Left ventricular failure | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Tachyarrhythmia | Cardiac disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Cerumen impaction | Ear and labyrinth disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Otorrhoea | Ear and labyrinth disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Tinnitus | Ear and labyrinth disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0023 events3 affected133 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Goitre | Endocrine disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hyperparathyroidism secondary | Endocrine disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hypothyroidism | Endocrine disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cataract | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0003 events3 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0022 events1 affected133 at risk
|
| Cataract nuclear | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Conjunctival haemorrhage | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Corneal oedema | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Diplopia | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dyschromatopsia | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Erythropsia | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Eye pain | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Eye swelling | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Eyelid cyst | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Eyelid oedema | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Glaucoma | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Lacrimation increased | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Lenticular opacities | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Macular degeneration | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Macular fibrosis | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Macular oedema | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Normal tension glaucoma | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Ocular hyperaemia | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Optic disc disorder | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Optic disc haemorrhage | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Photopsia | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Posterior capsule opacification | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Retinal drusen | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Retinal haemorrhage | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Visual acuity reduced | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Visual impairment | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Vitreous detachment | Eye disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Abdominal distension | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Abdominal tenderness | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Aphthous ulcer | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Barrett's oesophagus | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0015 events5 affected127 at risk
- EG0022 events1 affected133 at risk
|
| Dental caries | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0017 events6 affected127 at risk
- EG0027 events6 affected133 at risk
|
| Dry mouth | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Faeces discoloured | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Flatulence | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Functional gastrointestinal disorder | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hyperchlorhydria | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Large intestinal obstruction | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0024 events4 affected133 at risk
|
| Oral disorder | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Toothache | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Asthenia | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Chest discomfort | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Chest pain | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Chills | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Crying | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Fatigue | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0015 events5 affected127 at risk
- EG0027 events7 affected133 at risk
|
| Feeling abnormal | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Feeling cold | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Feeling jittery | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Gait disturbance | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Influenza like illness | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Injection site rash | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Malaise | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0017 events6 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Oedema | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Oedema peripheral | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0015 events4 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Pain | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Peripheral swelling | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Pyrexia | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Unevaluable event | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Vessel puncture site haematoma | General disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Cholecystitis chronic | Hepatobiliary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Allergy to animal | Immune system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hypersensitivity | Immune system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Mite allergy | Immune system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Mycotic allergy | Immune system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Seasonal allergy | Immune system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Acute sinusitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Bronchitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0023 events3 affected133 at risk
|
| Cellulitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Clostridium difficile infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Conjunctivitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dermatitis infected | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Diverticulitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| External ear cellulitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Folliculitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Fungal skin infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hepatitis e | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Herpes zoster | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hordeolum | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Influenza | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0014 events4 affected127 at risk
- EG0023 events3 affected133 at risk
|
| Laryngitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Localised infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Nail bed infection bacterial | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Nasopharyngitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0007 events7 affected55 at risk
- EG00116 events14 affected127 at risk
- EG0027 events7 affected133 at risk
|
| Onychomycosis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Oral herpes | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Otitis externa | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Otitis media | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Pharyngitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Rhinitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Sinusitis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Tinea versicolour | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Tooth infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0005 events5 affected55 at risk
- EG0016 events6 affected127 at risk
- EG0028 events7 affected133 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0005 events3 affected55 at risk
- EG0018 events7 affected127 at risk
- EG0023 events3 affected133 at risk
|
| Viral infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Viral upper respiratory tract infection | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Vulvovaginal candidiasis | Infections and infestations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Arthropod bite | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Back injury | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Compression fracture | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG00112 events11 affected127 at risk
- EG0024 events4 affected133 at risk
|
| Eye contusion | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0002 events1 affected55 at risk
- EG00112 events8 affected127 at risk
- EG0029 events8 affected133 at risk
|
| Fracture displacement | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Incision site pain | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0002 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Joint injury | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Laceration | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0014 events4 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Ligament sprain | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Limb injury | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Meniscus injury | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Muscle rupture | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0002 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Post procedural haematuria | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Post procedural swelling | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0023 events3 affected133 at risk
|
| Skin abrasion | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0003 events3 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Synovial rupture | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Alanine aminotransferase increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Aspartate aminotransferase increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Biopsy skin | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Blood alkaline phosphatase increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Blood cholesterol increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Blood creatine phosphokinase increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Blood creatinine increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Blood pressure increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Cardiac murmur | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Colonoscopy | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Cystoscopy | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Electrocardiogram qt prolonged | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Fibrin d dimer increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Haemoglobin decreased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hepatic enzyme increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Low density lipoprotein increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Mammogram abnormal | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Oxygen saturation decreased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Staphylococcus test positive | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Transaminases increased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Tri-iodothyronine decreased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Weight decreased | Investigations | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0023 events3 affected133 at risk
|
| Decreased appetite | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dyslipidaemia | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Gout | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hypercalcaemia | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hypercholesterolaemia | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hyperlipidaemia | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Vitamin d deficiency | Metabolism and nutrition disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0014 events4 affected127 at risk
- EG0028 events8 affected133 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Exostosis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Joint space narrowing | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Joint swelling | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Mobility decreased | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0004 events4 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Osteopenia | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Osteoporosis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0023 events3 affected133 at risk
|
| Periarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Rheumatoid arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Scoliosis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Synovial cyst | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Tendonitis | Musculoskeletal and connective tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Acrochordon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Dysplastic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Seborrhoeic keratosis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Skin papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0024 events4 affected133 at risk
|
| Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Amyloid related imaging abnormality-oedema/effusion | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Aphasia | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Ataxia | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Balance disorder | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cerebellar infarction | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cerebellar microhaemorrhage | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cerebellar syndrome | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Cerebral microhaemorrhage | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Corticobasal degeneration | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Dementia alzheimer's type | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dizziness | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0024 events4 affected133 at risk
|
| Dizziness postural | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dysgeusia | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Essential tremor | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Extrapyramidal disorder | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Head discomfort | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Headache | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0005 events5 affected55 at risk
- EG0014 events4 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Hypersomnia | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hypogeusia | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Lethargy | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Loss of consciousness | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Memory impairment | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Migraine | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Nervous system disorder | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Poor quality sleep | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Presyncope | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Somnolence | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Superficial siderosis of central nervous system | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Syncope | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Thalamic infarction | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Tremor | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Vertebral artery stenosis | Nervous system disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Abnormal dreams | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0014 events3 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Affect lability | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Agitation | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0023 events3 affected133 at risk
|
| Anxiety | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0003 events3 affected55 at risk
- EG0014 events4 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Confusional state | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0004 events3 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Delusion | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Depressed mood | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Depression | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0024 events3 affected133 at risk
|
| Disorientation | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0012 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Emotional distress | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Generalised anxiety disorder | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hallucination | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0016 events6 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Hallucination, auditory | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hallucination, visual | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0014 events4 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hypnopompic hallucination | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Insomnia | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0003 events3 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Mania | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Mood altered | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Mood swings | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Nightmare | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0015 events4 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Psychotic disorder | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Sleep disorder | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Suicidal ideation | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Tension | Psychiatric disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Acute kidney injury | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Dysuria | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Hypertonic bladder | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Lower urinary tract symptoms | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Pollakiuria | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Renal cyst | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Renal mass | Renal and urinary disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Breast cyst | Reproductive system and breast disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Breast mass | Reproductive system and breast disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Breast pain | Reproductive system and breast disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Genital rash | Reproductive system and breast disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Atelectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0006 events6 affected55 at risk
- EG0015 events5 affected127 at risk
- EG0023 events2 affected133 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0022 events1 affected133 at risk
|
| Lower respiratory tract congestion | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Nasal congestion | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Pleuritic pain | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Rhinitis allergic | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Actinic keratosis | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0013 events3 affected127 at risk
- EG0024 events3 affected133 at risk
|
| Dermatitis | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dermatitis atopic | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Dermatitis contact | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0005 events5 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Dry skin | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Eczema | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Eczema asteatotic | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Erythema | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hair colour changes | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hyperhidrosis | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Idiopathic guttate hypomelanosis | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Ingrowing nail | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Leukoderma | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Nail disorder | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Night sweats | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Pruritus | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events1 affected127 at risk
- EG0023 events1 affected133 at risk
|
| Psoriasis | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Rash macular | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Rash papular | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Seborrhoeic dermatitis | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Skin hypopigmentation | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0002 events2 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Skin irritation | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Skin lesion | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Solar lentigo | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0023 events1 affected133 at risk
|
| Splinter haemorrhages | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Telangiectasia | Skin and subcutaneous tissue disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Orthosis user | Social circumstances | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Walking aid user | Social circumstances | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Blepharectomy | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Bursa removal | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cataract operation | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0023 events2 affected133 at risk
|
| Catheter placement | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Chest tube insertion | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Cochlea implant | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Coronary artery bypass | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Dental implantation | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Endodontic procedure | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Internal fixation of fracture | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Intraocular lens implant | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Knee arthroplasty | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Lens capsulotomy | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Medical device removal | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Micrographic skin surgery | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Nasal operation | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Open reduction of fracture | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Papilloma excision | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Skin neoplasm excision | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Spinal fusion surgery | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Tooth extraction | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Transurethral prostatectomy | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Vertebroplasty | Surgical and medical procedures | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Aortic disorder | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Flushing | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Haematoma | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0022 events2 affected133 at risk
|
| Hot flush | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hypertension | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0010 events0 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Hypotension | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0012 events2 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Orthostatic hypertension | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0001 events1 affected55 at risk
- EG0015 events5 affected127 at risk
- EG0021 events1 affected133 at risk
|
| Supine hypertension | Vascular disorders | MedDRA 21.0 | Systematic Assessment | | - EG0000 events0 affected55 at risk
- EG0011 events1 affected127 at risk
- EG0020 events0 affected133 at risk
|